Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Drug Targets
Developers
Trial Sites
Trials
News
Meetings
Members
Our Members
Core Group
About
Join Us
Trial
TBTC Study 33/iAdhere: AdherenceC
Study Director
Start Date
9 / 2012
Trial Phase
Trial Status
in data analysis
Current Enrollment
1002
Target Enrollment
1000
Overview
Compound Associations
Rifapentine for Latent TB Infection (LTBI)